There aren't many biotechs that are more exciting than Viking Therapeutics (NASDAQ: VKTX) right now. Thanks to its ...
Analysts Predict a $102 Target for Viking Therapeutics Inc (VKTX) Stock—What Could Drive It There?
On Friday, Viking Therapeutics Inc (VKTX) stock saw a decline, ending the day at $49.58 which represents a decrease of $-3.99 or -7.45% from the prior close of $53.57. The stock opened at $53.18 and ...
Investors with a lot of money to spend have taken a bullish stance on Viking Therapeutics VKTX. And retail traders should ...
Equity markets have performed well in 2024, but their showing pales next to that of Viking Therapeutics (NASDAQ: VKTX), a mid ...
Right now, Eli Lilly dominates the weight loss industry thanks to its dual agonists Mounjaro and Zepbound. Viking ...
Viking Therapeutics stock is volatile Monday after the pharma company released positive data for its weight-loss drug. Here's ...
The Motley Fool on MSN11d
Got $5,000? Viking Therapeutics Stock Just Got a Big New Green FlagThe company's latest presentation supports the idea that its lead program will make billions.
MarketWatch on MSN14d
Viking Therapeutics stock jumps after weight-loss pill shows ‘great outcome’ in trialViking Therapeutics stock soared 21% in early trade Monday after the biotech posted data on its oral weight-loss drug showing ...
Viking Therapeutics shares climbed 9% on Monday after the drug developer's oral obesity treatment helped reduce body weight ...
Viking Therapeutics shares rose Monday morning before reversing course and declining after reporting the latest results from ...
Viking Therapeutics’ GLP-1 pill candidate for treating obesity showed promise in its latest trial results, the clinical-stage ...
Viking Therapeutics reported an 8.2% weight loss with VK2735, but a sell-off followed. Read why VKTX stock's long-term ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback